The dialogue between breast cancer and microorganisms
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1738739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Yan Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Chongging Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University…. Hauptthemen laut MEDLINE: Breast Neoplasms, Microbiota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer is a complex pathological process involving multiple factors and stages, characterized by pronounced molecular and phenotypic heterogeneity. Its global incidence and mortality rates have shown a continuous upward trend. With the advancement of microbiome research, microbial communities have been recognized as key determinants influencing host health and disease states. Increasing evidence suggests a close association between breast tissue–resident and systemic microbiota and the initiation and progression of breast cancer. Specifically, microorganisms may be associated with abnormal proliferation and malignant transformation of mammary epithelial cells through diverse mechanisms, including the modulation of estrogen metabolism, production of bioactive metabolites, induction of chronic inflammation, and remodeling of the tumor microenvironment. In addition, certain microbes may directly interact with host cells, potentially inducing DNA damage and contributing to the transition from normal to malignant phenotypes. This review systematically summarizes the origins and compositional characteristics of the breast microbiota, with a particular focus on current evidence regarding its roles in breast cancer initiation, progression, metastasis, therapeutic response, and prognosis. Currently, the majority of evidence originates from cross-sectional studies and in vitro / in vivo model, to better evaluate the current evidence, the limitations of different research designs and the levels of evidence are summarized in Table 1 , aiming to provide new theoretical insights and research perspectives for microbiota-based strategies in breast cancer diagnosis and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Chongging Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing, China.
- Department of Breast and Thyroid Surgery, Chongging Academy of Medical Sciences, Chongqing General Hospital, Chongqing, China.
- Department of Laboratory Medicine, Chongqing University Jiangjin Hospital, Chongqing, China.
Zitieren
APA
Zeng, Y., Jiang, Y., Huang, Y., Yin, S., Yang, Z., & Zhang, F. (2026). The dialogue between breast cancer and microorganisms. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1738739
Vancouver
Zeng Y, Jiang Y, Huang Y, Yin S, Yang Z, Zhang F. The dialogue between breast cancer and microorganisms. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1738739
BibTeX
@article{Zeng2026,
author = {Zeng, Yan and Jiang, Yuhang and Huang, Yinde and Yin, Supeng and Yang, Zeyu and Zhang, Fan},
title = {The dialogue between breast cancer and microorganisms},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1738739}
}
EUVIMED